| 9AM-10AM CST |
Overview of the Proposed Rule for Stage 2 Meaningful Use, Implementation Standards, and Certification Criteria |
| |
Abstract: Attendees to this session will be able to explain the proposed rules for Stage 2 Meaningful Use including, but not limited to, a focus on patient engagement, new quality measures, health information exchange, EHR usability, and pending financial adjustments (2015).
|
| 10:15AM-11:15AM CST |
Nuance Sponsored Session -
Pathway to Meaningful Use: Unlocking Valuable Information in Unstructured Documents |
| |
Abstract: Attendees will learn how the HL7 Clinical Document Architecture (CDA) can be used to meet proposed Stage 2 Meaningful Use requirements related to information exchange, data capture, quality measures, reporting, and more. In partnership with the Health Story Project, Nuance supports and promotes the HL7 CDA as a content standard which can be leveraged to unlock the value of patient information found in paper-based records and unstructured data.
| Speakers: |
Liora Alchsuler
Chief Executive Officer
Lantana Consulting Group
|
Carina Edwards
Vice President, Healthcare Solutions Marketing
Nuance Communications |
David McKanna
Healthcare Industry Marketing Manager, Imaging Division
Nuance Communications, Inc. |
|
| 11:30AM-12:30PM CST |
A Detailed Look at Stage 2 Meaningful Use: What Does it Mean for the Eligible Hospital? |
| |
Abstract: In this session, attendees will be able to describe the new definition of “meaningful use” and how it impacts your hospital based on revised Stage 1 and new Stage 2 proposed requirements. In addition, attendees will also recognize the changes of menu items to core measures; the impact to children’s hospitals eligibility requirements, timelines for meaningful use achievement; financial impact to the eligible hospital, and other aspects of the proposed rule.
|
| 12:45PM-1:45PM CST |
A Detailed Look at Stage 2 Meaningful Use: What Does it Mean for the Eligible Provider? |
| |
Abstract: Attendees to this session will recognize the impact of the proposed rules for the eligible provider including, but not limited to, adjustments to Stage 1 criteria and Stage 2 objectives for CPOE, laboratory and radiology, problem lists; and requirements for patient referrals and the transmission of data for immunizations and syndromic surveillance.
|
| 2PM-3PM CST |
Meaningful Use Clinical Quality Measures: Opportunities for the Provider Setting |
| |
Abstract: In this session, attendees will be able to recognize how clinical quality measures will be incorporated into the proposed definition of Stage 2 Meaningful Use while also being able to describe the changes to clinical quality measures; the use of structured data; and the concept of physician group quality reporting.
| Speakers: |
Brian Jacobs, MD, FHIMSS
VP & CMIO, Executive Director, Center for Pediatric Informatics
Children's National Medical Center
|
|
|
| 3:15PM-4:15PM CST |
A Meaningful Exchange of Information: Opportunities for HIEs and Public Health |
| |
Abstract: Attendees to this session will recognize, in detail, the robust health information exchange activities necessary to support Stage 2 Transition of Care and patient referrals objectives as well as the new public health reporting requirements.
|
| 4:30PM-5:30PM CST |
Standards, Implementation Specifications, and Certification Criteria: An Detailed Review |
| |
Abstract: In this session, attendees will recognize the impact of changes to technologies for standardized vocabularies, structured data, and usability requirements, for 2014 EHRs certification.
|